| |
| |
|
| Insider
Information: |
Bancroft Charles A |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
168,937 |
|
|
Indirect Shares
|
300,000 |
|
|
| Direct
Value |
$6,424,696 |
|
|
|
Indirect Value
|
$12,702,000 |
|
|
| Total
Shares |
468,937 |
|
|
| Total
Value |
$19,126,696 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Head of Integration |
2020-03-10 |
137,534 |
2020-03-10 |
300,000 |
Premium* |
|
|
Colgate Palmolive Co |
CL |
Director |
2018-05-14 |
5,455 |
2017-05-15 |
0 |
Premium* |
|
|
Kodiak Sciences Inc. |
KOD |
Director |
2020-04-02 |
25,948 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2016-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
187,794 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2016-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,403 |
192,801 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2017-02-28 |
4 |
OE |
$27.01 |
$610,372 |
D/D |
22,598 |
212,516 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,324 |
289,293 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2017-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,401 |
267,770 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-02-23 |
4 |
OE |
$22.14 |
$829,364 |
D/D |
37,460 |
302,348 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
91,318 |
363,739 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4/A |
OE |
$0.00 |
$0 |
D/D |
6,401 |
342,522 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,401 |
206,117 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2019-02-28 |
4 |
OE |
$17.51 |
$925,999 |
D/D |
52,884 |
392,690 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,255 |
411,547 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Head of Integration |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
71,868 |
153,637 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2012-12-17 |
4 |
S |
$32.77 |
$1,403,998 |
D/D |
(42,844) |
71,076 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2013-05-28 |
4 |
S |
$48.68 |
$1,217,000 |
D/D |
(25,000) |
94,015 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-02-14 |
4 |
S |
$54.35 |
$2,878,285 |
D/D |
(52,963) |
77,303 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-07-29 |
4 |
S |
$51.06 |
$3,452,532 |
D/D |
(67,621) |
96,564 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2016-05-20 |
4 |
S |
$70.79 |
$2,137,838 |
D/D |
(30,201) |
184,694 |
0 |
- |
|
117 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
